Metamark Genetics Nabs $10M in Financing | GenomeWeb

NEW YORK (GenomeWeb) – Metamark Genetics today said that it has secured $10 million in financing to further expand its clinical testing products and services in the US and abroad. 

The new funding, the company added, will allow it to complete the development of other urologic assay products. Metamark also announced that Shawn Marcell has resigned as president and CEO of the firm to pursue other opportunities. He has been replaced by Kenneth Weg, a Metamark co-founder and current chairman of the board of directors. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.